Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c ; Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Neurocrine Biosciences (NBIX) Tops Q4 EPS by 12c ; Offers Guidance

Neurocrine Bio. (NBIX) PT Lowered to $179 at BofA Securities

February 7, 2025 6:08 AM EST

BofA Securities analyst Tazeen Ahmad lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $179.00 (from $184.00) while maintaining a Buy rating.

The analyst comments "NBIX announced FY24 Ingrezza revenues of $2.31bn (+26% y/y, ours: $2.316bn, cons: $2.32bn). On FY25 outlook, the company guided to FY25 sales of... More